# Brighton Biotech, Inc.: Form D filings

Brighton Biotech, Inc., a biotechnology company in Fort Worth, TX, filed 3 Form D notices with the SEC between 2014 and 2015. The latest, on June 1, 2015, reports an offering of no set size with nothing sold yet to 3 investors.

Find out what Brighton Biotech, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Brighton%20Biotech%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Brighton%20Biotech%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbrighton-biotech-inc-1625381)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Brighton%20Biotech%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Brighton%20Biotech%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbrighton-biotech-inc-1625381)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: FORT WORTH CLUB BLDG., 306 W. 7TH STREET, SUITE 860, Fort Worth, TX, 76102
- Phone: (817) 821-3000
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1625381

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 1, 2015 | New notice | Indefinite | $0 | Indefinite | 3 | May 26, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1625381/000162538115000002/0001625381-15-000002-index.htm) |
| Nov 18, 2014 | Amendment | $2,500,000 | $1,600,000 | $900,000 | 20 | Nov 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1625381/000095010314008119/0000950103-14-008119-index.htm) |
| Nov 18, 2014 | New notice | $2,500,000 | $1,600,000 | $900,000 | 20 | Nov 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1625381/000095010314008107/0000950103-14-008107-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kevin Howard Hershberger | Executive Officer, Director |  |
| John A. White | Director |  |
| Jeffrey A. Gelfand | Director |  |
| Frances A. West | Director |  |
| Halden Howard Connor | Director |  |

## Other biotechnology companies in Texas that filed recently

- [Nuclein, LLC](https://specstream.ai/data/form-d/company/nuclein-llc-1787352) $15.7 million · Oct 27, 2026
- [OncoNano Medicine, Inc.](https://specstream.ai/data/form-d/company/onconano-medicine-inc-1735726) $10.1 million · Oct 8, 2026
- [Solaris Endovascular Inc.](https://specstream.ai/data/form-d/company/solaris-endovascular-inc-2156481) $5 million · Oct 1, 2026
- [Hera Biotech, Inc.](https://specstream.ai/data/form-d/company/hera-biotech-inc-1831293) $1.7 million · Sep 23, 2026
- [Kayak Therapeutics, Inc.](https://specstream.ai/data/form-d/company/kayak-therapeutics-inc-2088831) $25 million · Aug 21, 2026
- [InnovoTEX Inc.](https://specstream.ai/data/form-d/company/innovotex-inc-1971887) $2.7 million · Aug 18, 2026

[Every Form D from the week of Jun 1, 2015](https://specstream.ai/data/form-d/week/2015-06-01) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Brighton Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).